Skip to main content

Advertisement

SpringerLink
Log in

Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics 2015. CA Cancer J Clin 65(1):5–29

    Article  PubMed  Google Scholar 

  2. Merseburger AS, Hammerer P, Rozet F, Roumeguere T, Caffo O, da Silva FC, Alcaraz A (2015) Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy? World J Urol 33(8):1079–1085

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Moyad MA (2015) Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods. Asian J Androl. doi:10.4103/1008-682X.156854

    Google Scholar 

  4. Gandaglia G, Sun M, Popa I, Schiffmann J, Abdollah F, Trinh QD, Saad F, Graefen M, Briganti A, Montorsi F, Karakiewicz PI (2014) The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study. BJU Int 114(6b):E82–E89

    Article  CAS  PubMed  Google Scholar 

  5. Keating NL, O’Malley A, Freedland SJ, Smith MR (2012) Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst 104(19):1518–1523

    Article  PubMed  Google Scholar 

  6. Jespersen CG, Norgaard M, Borre M (2014) Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 65(4):704–709

    Article  CAS  PubMed  Google Scholar 

  7. Van Hemelrijck M, Garmo H, Holmberg L, Ingelsson E, Bratt O, Bill-Axelson A, Lambe M, Stattin P, Adolfsson J (2010) Absolute and relative risk of cardiovascular disease in men with prostate cancer results from the population-based PCBaSe Sweden. J Clin Oncol 28(21):3448–3456

    Article  PubMed  Google Scholar 

  8. Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF (2009) Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol 27(21):3452–3458

    Article  PubMed  Google Scholar 

  9. Ziaran S, Goncalves FM, Breza J Sr (2013) Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control. World J Urol 31(2):289–292

    Article  CAS  PubMed  Google Scholar 

  10. Parikh RA, Pascal LE, Davies BJ, Wang Z (2014) Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research. Asian J Androl 16(4):505–510

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Authors’ contribution

C. Liang developed the project; Z. Hao involved in data collection; K. Zhang analyzed the data; and L. Zhang wrote/edited the manuscript.

Author information

Author notes

    Authors and Affiliations

    1. Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology, Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui Province, People’s Republic of China

      Kaiping Zhang, Li Zhang, Zongyao Hao & Chaozhao Liang

    Authors
    1. Kaiping Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Li Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Zongyao Hao
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Chaozhao Liang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Chaozhao Liang.

    Ethics declarations

    Conflict of interest

    None.

    Ethical standard

    This study was approved by Ethics Committees regarding Human Research of the First Affiliated Hospital of Anhui Medical University.

    Additional information

    Kaiping Zhang and Li Zhang have contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Zhang, K., Zhang, L., Hao, Z. et al. Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?. World J Urol 34, 879–881 (2016). https://doi.org/10.1007/s00345-015-1700-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00345-015-1700-7

    Keywords

    Search

    Navigation